TREA

Jay M. MATTHEWS

Follow

Person

  • Collegeville, PA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    Hydroxypyridoxazepines as NRF2 activators
    • Patent number 11,945,826
    • Issue date Apr 2, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Mark Elban
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    TRPV4 antagonists
    • Patent number 11,260,049
    • Issue date Mar 1, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Edward J. Brnardic
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    TRPV4 antagonists
    • Patent number 11,229,623
    • Issue date Jan 25, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Edward J. Brnardic
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    NRF2 activators
    • Patent number 11,028,099
    • Issue date Jun 8, 2021
    • GlaxoSmithKline Intellectual Property Development Limited
    • Carl A. Brooks
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    TRPV4 antagonists
    • Patent number 10,590,077
    • Issue date Mar 17, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Edward J. Brnardic
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    TRPV4 antagonists
    • Patent number 10,588,891
    • Issue date Mar 17, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Edward J. Brnardic
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    HYDROXYPYRIDOXAZEPINES AS NRF2 ACTIVATORS
    • Publication number 20240352034
    • Publication date Oct 24, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Mark ELBAN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    HYDROXYPYRIDOXAZEPINES AS NRF2 ACTIVATORS
    • Publication number 20220204526
    • Publication date Jun 30, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Mark ELBAN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TRPV4 ANTAGONISTS
    • Publication number 20210299113
    • Publication date Sep 30, 2021
    • Edward J. BRNARDIC
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TRPV4 ANTAGONISTS
    • Publication number 20200261411
    • Publication date Aug 20, 2020
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Edward J. BRNARDIC
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NRF2 ACTIVATORS
    • Publication number 20200031846
    • Publication date Jan 30, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Carl A. BROOKS
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TRPV4 ANTAGONISTS
    • Publication number 20190216774
    • Publication date Jul 18, 2019
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Edward J. BRNARDIC
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TRPV4 ANTAGONISTS
    • Publication number 20190202784
    • Publication date Jul 4, 2019
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Edward J. BRNARDIC
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE